Real-World Example: Pharma CMO Automates Batch Record Review with Azure AI Foundry Agents Integrated to MES and LIMS

Real-World Example: Pharma CMO Automates Batch Record Review with Azure AI Foundry Agents Integrated to MES and LIMS

1. Problem / Context

For a $200M contract manufacturing organization (CMO) with a QA team of 20, batch record review can be the rate‑limiting step for lot release. Under cGMP with FDA and EMA oversight, every lot requires meticulous reconciliation of electronic batch records (eBR) and supporting PDFs against the master batch record (MBR) and specifications. Manual page‑flips, ad‑hoc spreadsheets, and fragile OCR scripts create delays, inconsistency, and audit risk—especially when serving multiple sponsors with varying formats.

The result is an operational squeeze: backlogs, late discovery of discrepancies, and lengthy QA touch time. In preparation for inspections, teams must also demonstrate data integrity and traceability, which is harder when evidence is scattered across MES, LIMS, and document repositories. This case study shows how governed agentic AI, orchestrated in Azure AI Foundry and integrated to MES and LIMS, accelerated release by 24%, surfaced discrepancies earlier, and increased first‑pass yield on QA review.

2. Key Definitions & Concepts

• Batch Record Review (BRR): The QA process of verifying recorded production activities and lab results against the MBR and specifications to determine release readiness.
• eBR and MBR: Electronic batch record (executed) and master batch record (approved recipe/specs).
• Deviation Detection and Reconciliation: Identifying out‑of‑range parameters, missing sign‑offs, or step deviations; comparing captured values to MBR/spec limits.
• MES and LIMS: Manufacturing Execution System and Laboratory Information Management System—authoritative systems for production steps and assay results.
• Agentic AI: AI agents that can read documents and data, reason over rules, coordinate tasks, and draft outputs for human review within a governed framework.
• Azure AI Foundry: The orchestration layer used to manage agents, prompts, evaluation, and versioned releases in a governed way.

3. Why This Matters for Mid-Market Regulated Firms

Mid‑market CMOs face the same cGMP and inspection pressures as large manufacturers, but with leaner QA teams and tighter budgets. They can’t afford bespoke integration projects that take a year to show value, nor can they risk uncontrolled AI pilots. They need governed, auditable automation that works across heterogeneous sponsor formats, supports human‑in‑the‑loop QA, and slots into existing MES/LIMS without destabilizing validated processes or creating GxP change‑control headaches.

4. Practical Implementation Steps / Roadmap

1. Data connections and scope:
2. Agentic workflow in Azure AI Foundry:
3. Human‑in‑the‑loop and packaging:
4. Integration and observability:

• Ingest eBR outputs from MES (structured exports and PDFs) plus supporting attachments (cleaning logs, line clearance forms).
• Pull assay results from LIMS and retrieve approved specs from the MBR and controlled documents.
• Define the initial product family and sponsor formats to minimize variability in the first iteration.

• Document understanding: Agents parse eBR/PDFs, normalize units, and extract critical parameters (e.g., temperatures, yields, hold times, signatures).
• Reconciliation engine: Agents compare extracted values to MBR/spec limits and procedural steps; verify completeness of signatures and timestamps.
• Deviation detection: Agents flag out‑of‑range values, missing sign‑offs, and sequencing anomalies; link each finding to evidence with page/line references.
• Draft QA comments: Agents generate concise, templated comments and proposed dispositions for QA reviewer approval.

• QA reviewers see a structured discrepancy list with evidence links, accept/modify comments, and record decisions.
• Agents compile a release readiness packet (findings log, reconciled parameter table, LIMS results, and approvals) for final QA sign‑off.

• Use APIs/connectors for MES and LIMS; maintain read‑only access for validation phases.
• Log all agent actions, model/prompt versions, and reviewer decisions to support cGMP auditability.

Kriv AI implements the above as governed agentic workflows, leveraging Azure AI Foundry for prompt catalogs, model versioning, evaluation gates, and controlled promotion to production—so pilots don’t stall at change control.

5. Governance, Compliance & Risk Controls Needed

• Data integrity (ALCOA+): Ensure entries are attributable, legible, contemporaneous, original, and accurate. Preserve source documents and maintain traceability from extracted values to evidence.
• Part 11/Annex 11 considerations: Enforce unique user accounts, electronic signatures where applicable, and secure, time‑stamped audit trails for all agent actions and human decisions.
• Human‑in‑the‑loop and segregation of duties: Agents draft; QA approves. No automatic disposition without human sign‑off. Role‑based access controls prevent conflicts.
• Change control under QMS: Prompts and models are locked, version‑controlled, and released through validation gates. Kriv AI uses Azure AI Foundry to version models and prompts and to validate changes before production, reducing GxP risk and avoiding the pilot‑graveyard.
• Validation and test harness: Maintain representative test sets (eBR formats, sponsor variants, typical deviations) with pass/fail criteria. Capture model drift and re‑validation triggers.
• Vendor lock‑in mitigation: Favor standards‑based interfaces; avoid brittle OCR‑only approaches by preferring structured MES exports when available; encapsulate agent logic so components can be swapped without revalidating the entire stack.

6. ROI & Metrics

This CMO achieved a 24% faster lot release, driven by earlier discrepancy detection and higher first‑pass yield on QA review. The gains come from reduced QA touch time, fewer late‑stage surprises, and clearer reviewer focus on high‑risk items rather than manual page‑flips.

What to measure:

• Cycle time: Calendar days from batch completion to disposition; target percentage reduction.
• First‑pass yield of QA review: Share of lots approved without rework.
• QA touch time: Total reviewer hours per lot for record review.
• Error and false‑positive rates: Accuracy of agent‑flagged deviations.
• Backlog and WIP: Lots waiting for QA review.
• Cost per lot and holding costs: Reduced inventory/warehouse time.

A realistic example: At 250 lots/year, saving just 3 hours of QA touch time per lot yields 750 hours annually. At a fully loaded $90/hour, that’s ~$67,500 in labor capacity freed—before counting reduced holding costs and avoided expedite fees. Improvements in first‑pass yield further compound savings by cutting rework loops.

7. Common Pitfalls & How to Avoid Them

• Fragile OCR scripts: Replace brittle templates with governed document understanding plus fallbacks to structured MES exports; keep a manual review path for edge cases.
• Prompt and model drift: Lock prompts, version models, and release changes through validation and change control with auditable approvals.
• Skipping validation: Establish test harnesses and acceptance criteria before go‑live; require re‑validation on data schema or model changes.
• Brittle integrations: Use API contracts, sandbox environments, and synthetic test data. Monitor for upstream schema changes.
• Over‑automation: Keep human‑in‑the‑loop for dispositions and deviations; automation drafts, QA decides.
• Unclear spec sources: Maintain a single source of truth for MBR/specs with strict document control.

30/60/90-Day Start Plan

• First 30 Days
• Days 31–60
• Days 61–90

• Discovery: Inventory product families, sponsor formats, and eBR/LIMS/MES data paths. Baseline cycle time, first‑pass yield, and QA touch time.
• Governance boundaries: Define human approval steps, segregation of duties, and audit trail requirements.
• Data readiness: Confirm access to MBR/specs, eBR exports, and LIMS data; map identifiers and units; identify gaps.
• Scope the pilot: Select 1–2 products with stable processes and available structured eBR outputs.

• Build pilot in Azure AI Foundry: Configure agents for document understanding, reconciliation rules, and deviation detection.
• Integrations: Connect read‑only to MES and LIMS; implement logging, RBAC, and secure connectivity.
• Human‑in‑the‑loop: Stand up the reviewer UI/queue; draft QA comment templates aligned to SOPs.
• Security and validation: Lock prompts, version models, and run the validation test harness; document results for QMS change control.
• Evaluation: Track accuracy, reviewer acceptance rates, and time saved; iterate within controlled change procedures.

• Scale: Expand to additional sponsor formats and product families; enable write‑backs where appropriate under change control.
• Monitoring: Establish drift detection, automated evaluation runs, and alerting; refresh validation data sets periodically.
• Metrics and reporting: Publish dashboards for cycle time, first‑pass yield, and backlog; review weekly with QA and operations.
• Stakeholder alignment: Update SOPs, training, and inspection readiness materials; plan the next wave of workflows.

9. Industry-Specific Considerations

• cGMP and inspections: Be inspection‑ready with clear traceability from each flagged deviation to underlying evidence and reviewer decisions.
• Annex 11/Part 11: Ensure electronic signatures, access controls, and audit trails meet regulatory expectations.
• GxP validation: Follow risk‑based validation aligned to GAMP 5; document intended use, acceptance criteria, and change history.
• Sponsor variability: Expect heterogeneous record formats; design parsing and rules to accommodate variants without constant revalidation.
• Genealogy and sampling: Link batch genealogy and LIMS samples to their steps in eBR for complete reconciliation.

10. Conclusion / Next Steps

Agentic AI, deployed in a governed manner, can transform batch record review from a manual bottleneck into a predictable, auditable, and faster process. By integrating Azure AI Foundry agents with MES and LIMS, this CMO accelerated release by 24%, detected discrepancies earlier, and improved first‑pass QA yield—without compromising cGMP rigor.

If you’re exploring governed Agentic AI for your mid‑market organization, Kriv AI can serve as your operational and governance backbone. As a governed AI and agentic automation partner, Kriv AI helps mid‑market teams stand up data‑ready, validated workflows, lock prompts and models, and move from pilot to production with confidence.